The Daily Hit: May 28, 2024

News from: New York Office of Cannabis Management, New Hampshire, Weedmaps, and more.

The Daily Hit is a recap of the top financial news stories for Tuesday, May 28, 2024.

On the Site

Top New York cannabis regulator resigns following rift with governor

The OCM executive director was supposed to remain on the job until Sept. 1, and it’s not clear now who will lead the agency going forward.

Read more here.

New Hampshire Senate approves recreational cannabis, but big hurdles remain

A key difference between the state Senate and House versions is who will own and operate the stores: government or private operators.

Read more here.

Weedmaps revenues fall as industry faces tightened marketing budgets

Weedmaps saw some metrics improve as it cut its non-paying clients.

Read more here.

Ayurcann losses contract on growing revenue in fiscal Q3

Though profitability continues to elude Ayurcann, the company made significant year-over-year progress.

Read more here.

Entourage Health sees revenues rise despite financial pressure

Entourage Health remains in breach of some financial covenants and is a going concern.

Read more here.

In Other News

Cronos Group

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) terminated its agreement with Future Farmco Canada Inc. for the sale and leaseback of its property located in Stayner, Ontario. Future Farmco failed to satisfy or waive its due diligence and financing condition by its May 27 deadline.

Read more here.

Innocann Pharma

Israel and Canada-based Innocan Pharma Corp. (CSE: INNO) (OTC: INNPF) reported first-quarter revenue of $6.8 million, compared to $1.6 million in the first quarter of 2023.

Read more here.

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE